Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117148) titled 'A Multicenter Chart Review and Doctor Survey on Current Treatment Patterns for Patients with Incurable/Non-metastatic Hepatocellular Carcinoma in China (SPHERE-M/CHANCE2503)' on Jan. 20.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
incurable/non-metastatic hepatocellular carcinoma
Intervention:
Case group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: Case group:1500;Doctor team:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html...